MedTrace Logo

DaVitri: Semi-Automated Vitrificacion Clinical Study

NCT05607771 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2023-08-01

No results posted yet for this study

Summary

The main objective of this clinical study is to demonstrate the non-inferiority of the semi automated device (DaVitri) developed by Overture Life in the preparation procedures for vitrification of human samples.

Conditions

  • Fertility Issues

Interventions

DEVICE

Manual Vitrification

Oocytes will be prepared for vitrification using the manual protocol

DEVICE

Automated Vitrification

Oocytes will be prepared for vitrification using the DaVitri device

Sponsors & Collaborators

  • Overture Life

    lead INDUSTRY

Principal Investigators

  • Fernando Neuspiller, MD · WeFiv

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
30 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-07-20
Primary Completion
2024-07-30
Completion
2024-07-30

Countries

  • Argentina

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05607771 on ClinicalTrials.gov